<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"papillary thyroid carcinoma":105,
"robotic":2,
"Cancer metabolism":3,
"PKM2":4,
"calcitonin":10,
"liver":3,
"medullary thyroid carcinoma":26,
"metastasis":34,
"thyroid":108,
"Ablation":3,
"Bajo riesgo":2,
"Cáncer diferenciado de tiroides":2,
"Differentiated thyroid cancer":21,
"Iodine-131":4,
"Low risk":2,
"Personalized medicine":2,
"Radioiodine":4,
"Recurrence":19,
"hyperthyroidism":7,
"scintigraphy":4,
"immunotherapy":4,
"next-generation sequencing":3,
"thyroid FNA":2,
"thyroid cancer":169,
"Bethesda System":3,
"FNA":7,
"dog":4,
"hypercalcemia":2,
"incidental":2,
"tumor":7,
"ultrasound":36,
"medullary thyroid cancer":16,
"prophylactic thyroidectomy":3,
"fine-needle aspiration biopsy":6,
"systematic review":2,
"thyroid malignancy":8,
"thyroid neoplasia":2,
"Cáncer de tiroides":5,
"TSH":4,
"Hemithyroidectomy":3,
"Hypothyroidism":11,
"Thyroid-stimulating hormone":4,
"BRAF":29,
"prognosis":26,
"Genetics":4,
"Oncology":5,
"Risk factor":2,
"Anaplastic thyroid carcinoma":13,
"Breast neoplasms":5,
"molecular targeted therapy":2,
"thyroid nodule":46,
"Ampliamente invasivo":2,
"Carcinoma folicular":2,
"Diferenciación":2,
"Differentiation":3,
"Follicular carcinoma":10,
"Invasion":10,
"Invasive":2,
"Invasión":2,
"Minimally invasive":2,
"Mínimamente invasivo":2,
"Prognostic factors":2,
"Thyroid gland":15,
"Tiroides":3,
"I-131":2,
"Thymus":2,
"Whole body scan":2,
"Thyroid papillary cancer":2,
"genetic polymorphism":2,
"single nucleotide polymorphism":2,
"pyruvate kinase":2,
"risk":5,
"second malignancy":2,
"thyroid neoplasm":8,
"Kinase inhibitors":2,
"Follicular thyroid cancer":5,
"Neck dissection":6,
"Surgery":13,
"androgen receptor":2,
"molecular radiotherapy":2,
"prostate cancer":8,
"theranostic":2,
"Elderly":2,
"mRNA":2,
"Apoptosis":14,
"PPARγ":2,
"Akt":5,
"Immunohistochemistry":30,
"MiR-21":2,
"Thyroid cancer, papillary":4,
"Thyroid neoplasms":43,
"Thyroiditis":4,
"Ultrasonography":29,
"genetic testing":2,
"multiple endocrine neoplasia":6,
"adenocarcinoma":7,
"adenoid cystic carcinoma":2,
"cytology":23,
"fine-needle aspiration":16,
"lymphoma":7,
"renal cell carcinoma":10,
"squamous cell carcinoma":3,
"fine Needle aspiration":12,
"central neck dissection":4,
"hypoparathyroidism":5,
"total thyroidectomy":11,
"vocal cord paralysis":2,
"breast cancer":37,
"synchronous neoplasms":2,
"differentiated thyroid carcinoma":16,
"thyroid peroxidase":2,
"Epidemiology":11,
"Outcome":6,
"RAS":9,
"TERT":4,
"FDG":4,
"Head and neck":3,
"PET/CT":9,
"MicroRNA":9,
"Papillary thyroid cancer":35,
"Plasma":3,
"Tumor size":4,
"quality of life":4,
"Hepatocellular carcinoma":11,
"Inflammation":4,
"NF-κB":3,
"Proliferation":11,
"TLR4":2,
"CT":5,
"Incidental thyroid nodule":2,
"Cancer":41,
"reactive oxygen species":2,
"autoimmunity":2,
"diabetes":2,
"hepatitis C virus":2,
"pathology":4,
"sonography":14,
"nodule size":3,
"External radiotherapy":2,
"Organ Preservation":2,
"sunitinib":5,
"thyrotoxicosis":2,
"angiogenesis":6,
"thyroid carcinoma":41,
"radioiodine therapy":9,
"canine":3,
"thyroid tumors":3,
"radionuclide therapy":2,
"Multiple endocrine neoplasia type 2":2,
"RET":10,
"Lung adenocarcinoma":7,
"Malignant":3,
"Metastatic carcinoma":3,
"Struma Ovarii":6,
"Thyroidectomy":30,
"RNA interference":2,
"glycolysis":4,
"Epithelial-mesenchymal transition (EMT)":2,
"lymph node metastasis":11,
"Neoplasm":4,
"IMP3":2,
"Vitamin D":5,
"biopsy":8,
"terminology":2,
"hyperparathyroidism":3,
"parathyroidectomy":4,
"Papillary carcinoma":24,
"Positron emission tomography":3,
"Hyperprolactinemia":2,
"prolactinoma":2,
"Hashimoto disease":2,
"fine-needle aspiration cytology":10,
"clear cell carcinoma":3,
"lymph node metastases":4,
"salivary gland":2,
"bilateral axillo-breast approach":2,
"robotic thyroidectomy":4,
"TR4":2,
"liquid-based cytology":4,
"larynx cancer":2,
"larynx":4,
"central lymph nodes":2,
"radioactive iodine":9,
"thyroglobulin":14,
"robot":3,
"Computed tomography":7,
"neuroblastoma":2,
"morphology":2,
"radiation":6,
"MEN2":3,
"Lymph node":8,
"Thyroid nodules":15,
"Carcinomas":2,
"Thyroglossal duct cyst":4,
"Neck mass":3,
"Thyroid hormone":5,
"chemotherapy":4,
"Incidental findings":4,
"imaging":3,
"incidentaloma":6,
"Autoimmune thyroid diseases":2,
"Cytokines":2,
"Graves' disease":2,
"Hashimoto's thyroiditis":5,
"BRAF V600E mutation":2,
"Acoustic Radiation Force Impulse":4,
"Chernobyl":4,
"Polymorphism":7,
"MTC":2,
"autophagy":4,
"medullary":4,
"Carcinoma":14,
"Ovary":2,
"E-cadherin":2,
"Migration":7,
"ALK":2,
"gene rearrangement":2,
"Carcinogenicity":2,
"Cancer de la thyroïde":2,
"Molecular biology":3,
"Targeted therapy":6,
"immunocytochemistry":7,
"Graves’ disease":4,
"Échographie":2,
"Doppler":2,
"Gene mutation":2,
"overall survival":3,
"elastography":10,
"head and neck ultrasound":13,
"Doppler sonography":2,
"calcification":4,
"diffuse large B-cell lymphoma":3,
"nodular goiter":2,
"thyroid ultrasound":2,
"Tyrosine kinase inhibitors":7,
"esophageal squamous cell carcinoma":3,
"synchronous":2,
"follicular":7,
"neoplasm metastasis":2,
"cyclophosphamide":3,
"neoadjuvant chemotherapy":4,
"predictive factor":3,
"management":3,
"radiation therapy":3,
"safety":3,
"Lymph nodes":4,
"Fine needle aspiration biopsy":5,
"pathogenesis":2,
"therapy":5,
"Pregnancy":3,
"BRAFV600E mutation":3,
"Cancer screening":3,
"Disease progression":2,
"Incidence":13,
"FNAC":2,
"non-small cell lung cancer":3,
"biomarkers":6,
"proteomics":4,
"Hurthle cells":2,
"Recurrent laryngeal nerve palsy":3,
"Cancer thyroïdien":4,
"Cementoplasty":2,
"Metastases":6,
"Radiofrequency":2,
"Adverse effects":3,
"Levothyroxine":3,
"Traitement":2,
"MAPK pathway":2,
"Next Generation Sequencing":4,
"China":2,
"Diagnosis":16,
"lymphatic metastasis":3,
"Thyroid surgery":4,
"parathyroid":6,
"Gene expression":4,
"follicular adenoma":4,
"goiter":5,
"neoplasms":12,
"autotaxin":2,
"chemoresistance":3,
"gene":2,
"mutation":12,
"Bone metastases":3,
"Cirugía":2,
"Dosimetry":3,
"KRAS":2,
"Malignancy":9,
"Shear wave elastography":5,
"FISH":2,
"body mass index":2,
"risk factors":3,
"Carcinoma diferenciado de tiroides":2,
"Distant metastases":2,
"Poorly differentiated thyroid carcinoma":4,
"cell migration":2,
"epithelial-mesenchymal transition":3,
"HBME-1":3,
"BRAF inhibitor":2,
"sorafenib":9,
"tyrosine kinase inhibitor":4,
"Therapeutic target":3,
"Prognostic factor":2,
"Surgical resection":2,
"Occult":2,
"autoimmune thyroiditis":3,
"The Bethesda System for Reporting Thyroid Cytopathology":2,
"frozen section":3,
"pediatric":8,
"PET":5,
"acromegaly":2,
"pituitary adenomas":2,
"accuracy":3,
"follow-up":4,
"lung":6,
"survival":13,
"treatment":7,
"multifocal":2,
"BRAF mutation":10,
"Dedifferentiated thyroid carcinoma":3,
"MRI":7,
"Children":2,
"Nodule":7,
"Thyroid disease":3,
"Surveillance":2,
"Survivors":2,
"Reoperation":2,
"Contrast-enhanced ultrasound":2,
"biological markers":2,
"mutations":2,
"follicular lesion of undetermined significance":2,
"follicular neoplasms":3,
"Kidney neoplasms":2,
"Liver metastasis":2,
"Bim":2,
"meta-analysis":19,
"Hürthle cell carcinoma":3,
"differentiated thyroid":2,
"papillary":13,
"Thyroid autoimmunity":2,
"Medullary carcinoma":4,
"NKX2-1":2,
"microRNA-365":2,
"cytopathology":5,
"EGFR":4,
"TP53":5,
"Horner's syndrome":2,
"Sarcoma":4,
"neoplasia":2,
"head and neck cancer":4,
"radiotherapy":10,
"thyroid hormone withdrawal":2,
"breast":7,
"Randomized controlled trial":2,
"circadian clock":2,
"thyroid hormones":4,
"follicular lesions":3,
"mortality":7,
"Angiogenesis inhibitors":2,
"Thyroid function test":2,
"mRCC":2,
"Anaplastic":3,
"Early detection of cancer":3,
"Iodine-refractory":2,
"VEGF":3,
"depression":2,
"Review":7,
"outcomes":2,
"Hypocalcemia":2,
"papillary thyroid microcarcinoma":4,
"Tumor heterogeneity":2,
"Anaplastic thyroid cancer":10,
"CD74":2,
"macrophage migration inhibitory factor":2,
"indeterminate":3,
"Sentinel lymph node biopsy":2,
"Cabozantinib":3,
"Guidelines":4,
"Vandetanib":5,
"RET gene":2,
"Decision support techniques":2,
"Korea":3,
"Prevalence":3,
"Molecular":3,
"pleural effusion":2,
"subacute thyroiditis":2,
"Hashimoto thyroiditis":5,
"calcium":3,
"parathyroid hormone":3,
"surgical excision":2,
"ionizing radiation":2,
"oxidative stress":3,
"risk assessment":3,
"HLA-F":2,
"Decision aids":2,
"Lung cancer":7,
"HDAC":2,
"Thyroid tumor":2,
"CT, computed tomography":4,
"MRI, magnetic resonance imaging":4,
"galectin-3":3,
"Autonomously functioning thyroid nodule":2,
"papillary microcarcinoma":2,
"BRAFV600E":2,
"RET/PTC1":2,
"Magnetic resonance imaging":2,
"multifocality":3,
"Nódulo tiroideo":2,
"trends":2,
"Surgical treatment":3,
"Thyroid microcarcinoma":2,
"Carcinoma papilar":3,
"Neoplasias da glândula tireoide":3,
"RET proto-oncogene":3,
"radioiodine scan":2,
"p53":4,
"Neck":4,
"Japanese":2,
"PAX8":3,
"follicular thyroid carcinoma":5,
"rearrangement":3,
"Follicular variant":4,
"TTF-1":4,
"radioiodine whole-body scan":2,
"survival analysis":2,
"Shear wave":2,
"Thyroid nodule evaluation":2,
"DTC":3,
"biomarker":6,
"FFPE":3,
"Thyroid function":2,
"NK cells":2,
"cell cycle":2,
"neuroendocrine":2,
"atypia of undetermined significance":2,
"genetic susceptibility":2,
"mTOR":5,
"TGF-β":2,
"Hashimoto’s thyroiditis":7,
"Cx43":2,
"Nasal cavity":3,
"breast metastasis":2,
"brain":2,
"cancer survival":2,
"CDX2":2,
"TTF1":2,
"Extrathyroidal extension":3,
"Neuroendocrine tumors":2,
"Cancer incidence":2,
"size":2,
"Breast carcinoma":2,
"overdiagnosis":3,
"Hurthle cell":2,
"PTC":3,
"miR-146b":2,
"adenoma":5,
"methylene blue":2,
"Surveillance, Epidemiology, and End Results (SEER)":2,
"disparities":3,
"thyroid hormone receptor":3,
"receptor":2,
"SEER":2,
"second primary malignancies":2,
"histopathology":5,
"microcarcinoma":4,
"Mitochondria":2,
"Poorly differentiated thyroid cancer":3,
"Radioiodine treatment":2,
"carbon nanoparticle":2,
"BRAF mutations":2,
"Hemostasis":2,
"sialadenitis":2,
"Methylation":4,
"nasopharynx":2,
"radioactive iodine ablation":4,
"core needle biopsy":2,
"FNAB":4,
"Ultrasound elastography":2,
"Obesity":4,
"Melanoma":5,
"rearranged during transfection":3,
"Primary thyroid lymphoma":2,
"Rhabdomyosarcoma":2,
"remnant ablation":2,
"Bethesda":4,
"Colorectal cancer":3,
"paraganglioma":3,
"napsin A":3,
"thyrotropin":3,
"BRAF V600E":4,
"thyroid metastasis":3,
"nodular goitre":2,
"Oral cavity":3,
"General practitioner":2,
"Médecin généraliste":2,
"Pheochromocytoma":3,
"Organ doses":2,
"C-cell hyperplasia":2,
"Bone metastasis":2,
"adverse events":3,
"epidermal growth factor receptor":2,
"pyruvate kinase M2":4,
"Sodium iodide symporter":2,
"familial adenomatous polyposis":2,
"germ cell tumour":2,
"neuroendocrine tumor (NET)":2,
"double primary cancers":2,
"Axillary lymph node dissection":2,
"lenvatinib":5,
"phase 2":2,
"diagnostic accuracy":2,
"miRNA":2,
"molecular marker":2,
"Thyroid cytology":2,
"Staging":2,
"Colon cancer":2,
"RET mutation":3,
"Fukushima":2,
"Total laryngectomy":2,
"Capsular invasion":2,
"Thyroid cartilage":2,
"Pancreatic cancer":5,
"mass spectrometry":2,
"TT cells":2,
"pten":3,
"Tumorigenesis":2,
"sensitivity":2,
"specificity":3,
"Hyalinizing trabecular tumor":2,
"FDG PET/CT":2,
"Cyclin D1":2,
"β-Catenin":5,
"Thyroid papillary carcinoma":2,
"Thyroid cancer cells":2,
"second primary neoplasms":2,
"prospective study":2,
"neuroendocrine tumor":2,
"small cell carcinoma":3,
"hypoxia inducible factor-1α":2,
"Molecular marker testing":2,
"Adolescent":2,
"Teenage":2,
"Complication":2,
"Differential diagnosis":3,
"texture analysis":2,
"Extracapsular Spread":2,
"Foxa2":2,
"metabolic syndrome":2,
"FOXO1":2,
"vascular invasion":2,
"differentiated":2,
"thyroid papillary microcarcinoma":2,
"Cervical lymph node":2,
"Fine needle aspiration cytology":3,
"vemurafenib":2,
"Lung carcinoma":2,
"Neuroendocrine carcinoma":2,
"Teratoma":2,
"MMP-9":2,
"thyroid follicular lesions":2,
"solid":2,
"RET/PTC":2,
"Radionuclide":2,
"FOXE1":2,
"Preoperative localization":2,
"Primary hyperparathyroidism":5,
"Learning curve":2,
"MCF-7":2,
"spinal metastasis":2,
"iodine radioisotopes":2,
"follicular variant of papillary thyroid carcinoma":2,
"Polymerase chain reaction (PCR)":2,
"Pituitary adenoma":2,
"thyroid transcription factor 1":3,
"Rats":2,
"Afirma":2,
"thyroid imaging":2,
"Next generation sequencing (NGS)":2,
"fine-needle aspiration cytology (FNAC)":2,
"complications":2,
"Bortezomib":2,
"ERK":2,
"Cholangiocarcinoma":2,
"hypoxia":2,
"Kidney tumor":2,
"translocation":2,
"Endocrine":2,
"Undifferentiated thyroid carcinoma":2,
"metformin":2,
"Hypothyroid":2,
"minimally invasive surgery":2,
"siRNA":2            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2015年论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
